Actionnariat et activité des initiés pour Organogenesis Holdings Inc. (ORGO): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $1.39 |
| Capitalisation | $179M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $1.0M | $125886 | $21.3M | $60.2M | $84.4M | $113.9M | $102.5M | $104.3M | $135.6M | $93.7M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | 0 | 0 | $34.1M | $39.4M | $56.8M | $82.5M | $89.5M | $82.0M | $109.9M | $217.5M |
| Stocks | 0 | 0 | $13.3M | $22.9M | $27.8M | $25.0M | $24.8M | $28.3M | $26.2M | $29.6M |
| Actifs Courants | $1.4M | $294439 | $71.1M | $125.6M | $174.3M | $227.0M | $222.6M | $225.0M | $285.9M | $362.2M |
| Immobilisations Corporelles | 0 | 0 | $39.6M | $47.2M | $55.8M | $128.3M | $145.7M | $156.3M | $126.2M | $159.5M |
| Goodwill | 0 | 0 | $25.5M | $25.5M | $28.8M | $28.8M | $28.8M | $28.8M | $28.8M | $28.8M |
| Actifs Incorporels | 0 | 0 | $26.1M | $20.8M | $30.6M | $25.7M | $20.8M | $15.9M | $12.5M | $9.1M |
| Actifs Totaux | $311.4M | $312.8M | $163.7M | $220.7M | $290.2M | $443.3M | $449.4M | $460.0M | $497.9M | $598.7M |
| Dettes Fournisseurs | 0 | $19.1M | $19.2M | $28.4M | $23.4M | $29.3M | $32.3M | $30.7M | $28.9M | $31.9M |
| Dette à Court Terme | 0 | $100000 | $2.5M | 0 | $16.7M | $2.7M | $4.5M | $5.5M | 0 | $18.6M |
| Passifs Courants | $478360 | $3.9M | $66.4M | $59.9M | $68.2M | $82.7M | $75.0M | $80.5M | $77.5M | $100.1M |
| Dette à Long Terme | 0 | 0 | $39.1M | $83.1M | $53.0M | $70.8M | $66.2M | $60.7M | 0 | $50.7M |
| Passifs Totaux | $11.3M | $14.8M | $116.6M | $165.1M | $148.4M | $201.9M | $183.7M | $181.4M | $112.6M | $164.8M |
| Réserves | -$233860 | -$2.3M | -$130.2M | -$171.0M | -$155.0M | -$60.8M | -$45.3M | -$41.0M | -$40.1M | -$3.1M |
| Capitaux Propres | $300.1M | $298.0M | $47.0M | $55.6M | $141.8M | $241.3M | $265.7M | $278.7M | $385.3M | $433.9M |
| Dette Totale | 0 | $17.9M | $59.3M | $100.6M | $84.8M | $132.3M | $123.8M | $119.4M | $43.3M | $132.8M |
| Dette Nette | -$1.0M | $17.7M | $38.0M | $40.4M | $377000 | $18.4M | $21.3M | $15.0M | -$92.3M | $39.2M |
| Fonds de Roulement | $957551 | -$3.6M | $4.7M | $65.7M | $106.1M | $144.3M | $147.6M | $144.5M | $208.5M | $262.1M |
Santé financière
| Dette / Capitaux propres | 0.23 |
| Ratio de liquidité | 3.52 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 4.16 |
Rentabilité
| Rentabilité des capitaux propres | -24.23% |
| Rentabilité du capital investi | -8.12% |
| Rentabilité des actifs | -22.20% |
| Marge brute | 67.59% |
| Marge opérationnelle | -6.38% |
| Marge nette | -19.76% |
Entreprises liées: ANGO · BCYC · CMPX · EBS · EOLS · ESPR · MNPR
Explorer le secteur: Healthcare · Drug Manufacturers - Specialty & Generic
Plus de sections de ORGO: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions